연구
-
-
연구
-
연구업적
연구업적
최근 5년 연구업적 현황
| 연도 | 2023년 | 2022년 | 2021년 | 2020년 | 2019년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 173편 | 163편 | 184편 | 135편 | 144편 |
| 공동 | 120편 | 115편 | 136편 | 168편 | 167편 | |
| 합계 | 293편 | 278편 | 320편 | 303편 | 311편 | |
2571. ATR inhibition amplifies antitumor effects of olaparib in biliary tract cancer
Ah-Rong Nam 1, Jeesun Yoon 2, Mei-Hua Jin 1, Ju-Hee Bang 1, Kyoung-Seok Oh 1, Hye-Rim Seo 3, Jae-Min Kim 3, Tae-Yong Kim 4, Do-Youn Oh 5
Cancer Lett
. 2021 Sep 28;516:38-47.
Link
2570. WEE1 inhibition reverses trastuzumab resistance in HER2-positive cancers
Mei-Hua Jin 1, Ah-Rong Nam 1, Ju-Hee Bang 1, Kyoung-Seok Oh 1, Hye-Rim Seo 1 2, Jae-Min Kim 1 2, Jeesun Yoon 3, Tae-Yong Kim 1 3, Do-Youn Oh 4 5 6
Gastric Cancer
. 2021 Sep;24(5):1003-1020.
Link
2569. Inhibition of WEE1 Potentiates Sensitivity to PARP Inhibitor in Biliary Tract Cancer
Hye-Rim Seo 1 2, Ah-Rong Nam 1, Ju-Hee Bang 1, Kyoung-Seok Oh 1, Jae-Min Kim 1 2, Jeesun Yoon 3, Tae-Yong Kim 1 3, Do-Youn Oh 1 3 2
Cancer Res Treat
. 2021 Aug 6
Link
2568. Targeting Hypoxia Using Evofosfamide and Companion Hypoxia Imaging of FMISO-PET in Advanced Biliary Tract Cancer
Jeesun Yoon 1, Seo Young Kang 2, Kyung-Hun Lee 1 3, Gi Jeong Cheon 2 3, Do-Youn Oh 1 3
Cancer Res Treat
. 2021 Apr;53(2):471-479.
Link
2567. The prognostic role of soluble transforming growth factor-β and its correlation with soluble programmed death-ligand 1 in biliary tract cancer
Jin Won Kim 1, Kyung-Hun Lee 2 3, Ji-Won Kim 1, Koung Jin Suh 1, Ah-Rong Nam 3, Ju-Hee Bang 3, Mei Hua Jin 3, Kyoung-Seok Oh 3, Jae-Min Kim 3, Tae-Yong Kim 2 3, Do-Youn Oh 2 3
Liver Int
. 2021 Feb;41(2):388-395.
Link
2566. Prospective evaluation of metabolic intratumoral heterogeneity in patients with advanced gastric cancer receiving palliative chemotherapy
Shin Hye Yoo 1, Seo Young Kang 2 3, Jeesun Yoon 1, Tae-Yong Kim 1 4, Gi Jeong Cheon 2 3, Do-Youn Oh 5 6
Sci Rep
. 2021 Jan 12;11(1):296
Link
2565. Prognostic Value of Serum Soluble Programmed Death-Ligand 1 and Dynamics During Chemotherapy in Advanced Gastric Cancer Patients
Woochan Park 1, Ju-Hee Bang 2, Ah-Rong Nam 2, Mei Hua Jin 2, Hyerim Seo 2, Jae-Min Kim 2, Kyoung Seok Oh 2, Tae-Yong Kim 1 2, Do-Youn Oh 1 2
Cancer Res Treat
. 2021 Jan;53(1):199-206.
Link
2564. Mapping of the perigastric lymphatic network using indocyanine green fluorescence imaging and tissue marking dye in clinically advanced gastric cancer
Park JH, Berlth F, Wang C, Wang S, Choi JH, Park SH, Suh YS, Kong SH, Park DJ, Lee HJ, Kwak Y, Kim WH, Yang HK
Eur J Surg Oncol. 2021 Aug 27:S0748-7983(21)00701-0
Link
2563. Glucose metabolic profiles evaluated by PET associated with molecular characteristic landscape of gastric cancer
Bae SW, Berlth F, Jeong KY, Park JH, Choi JH, Park SH, Suh YS, Kong SH, Park DJ, Lee HJ, Lee C, Kim JI, Youn H, Choi H, Cheon GJ, Kang KW, Yang HK
Gastric Cancer. 2021 Aug 7
Link
2562. Can endoscopic ultrasonography (EUS) improve the accuracy of clinical T staging by computed tomography (CT) for gastric cancer?
Lee KG, Shin CI, Kim SG, Choi J, Oh SY, Son YG, Suh YS, Kong SH, Lee HJ, Kim SH, Lee KU, Kim WH, Yang HK
Surg Oncol. 2021 Aug;47(8):1969-1975
Link